Thermo Fisher Scientific Rapid RT-PCR Accula Flu A/Flu B Test

Thermo Fisher Scientific has released the RT-PCR Accula Flu A/Flu B Test, a rapid, point-of-care RT-PCR test that enables healthcare providers to detect and differentiate influenza A and B in about 30 minutes. The test runs on the palm-sized, portable Accula Dock, which plugs into a standard wall outlet to enable RT-PCR testing without the need for a specialized laboratory, the company said. Thermo Fisher acquired Mesa Biotech, the company that developed and commercialized the Accula platform, in 2021. The Accula Dock and Accula Flu A/Flu B test received 510(k) clearance and CLIA waived status in 2018 from the US Food and Drug Administration.